Search

Your search keyword '"Yarnold J"' showing total 574 results

Search Constraints

Start Over You searched for: Author "Yarnold J" Remove constraint Author: "Yarnold J" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
574 results on '"Yarnold J"'

Search Results

1. Simulation of a radiobiology facility for the Centre for the Clinical Application of Particles

2. Partial Breast Radiotherapy for Women with Early Breast Cancer: 10-Year Outcomes from IMPORT LOW (CRUK/06/003)

6. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

8. OC-0101 First results of FAST-Forward phase 3 RCT nodal substudy: 3-year normal tissue effects

19. Simulation of a radiobiology facility for the Centre for the Clinical Application of Particles

22. FAST Phase III RCT of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015)

24. EP-1315: KORTUC phase I/II trial testing a novel radiation sensitiser in breast cancer: preliminary results

25. OC-0061: Big-RT: Big Data analysis to identify predictors of radiotherapy toxicity for personalised treatment

26. OC-0595: FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy:3-year normal tissue effects

32. SP-0314: Partial breast radiotherapy after breast conservation: 5 year outcomes from the IMPORT LOW (CRUK/06/003) phase III trial

34. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1

37. It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence

40. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer

41. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†

42. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer.

44. ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer

50. Radiotherapy for breast cancer, the TARGIT-A trial

Catalog

Books, media, physical & digital resources